Alnylam Pharmaceuticals
ALNY
Reported
Thursday, October 31
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.93 | -0.50 | 0.43 | 46.24% |
| Revenue | 533M | 501M | -32.2M | -6.04% |
WhatIF - Earnings
EPS Beat Expectations by $0.43
Alnylam Pharmaceuticals (ALNY:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything